Medicine and Dentistry
Mohs Surgery
100%
Nodular Melanoma
80%
Neoplasm
56%
Drug Therapy
53%
Malignant Neoplasm
42%
Scalp
38%
Immunotherapy
36%
Sentinel Lymph Node Metastasis
33%
Calciphylaxis
33%
Skin Manifestation
33%
Major Bleeding
33%
Immune-Related Adverse Events
33%
Tranexamic Acid
33%
Metastatic Carcinoma
33%
Bleeding
33%
Programmed Cell Death
33%
Cutaneous Melanoma
33%
Sentinel Lymph Node Biopsy
33%
Randomized Clinical Trial
33%
Subcutaneous Injection
33%
Acantholytic Dyskeratosis
33%
Warfarin
33%
Skin Surgery
33%
Cytarabine
33%
Bowen's Disease
33%
Electronic Patient Record
33%
Verruca Vulgaris
33%
Retrospective Cohort Study
33%
Brimonidine
33%
Antithrombotic
33%
Sentinel Node
33%
Monocyte
33%
Health Care Utilization
33%
Lymph Node Metastasis
26%
Erythema
25%
Biopsy
18%
Glans Penis
16%
Recurrent Disease
13%
Placebo
13%
Face Erythema
13%
Papule
11%
Purpuric Rash
11%
Hazard Ratio
10%
Surveillance, Epidemiology, and End Results
8%
Oncology
8%
Surgeon
6%
Self-Diagnosis
6%
Health Care Cost
6%
Clinical Decision Making
6%
Reactive Oxygen Species
6%
Keyphrases
Mohs Micrographic Surgery
38%
Penile Squamous Cell Carcinoma
33%
Statin Use
33%
Tranexamic Acid
33%
Cutaneous Warts
33%
Acantholytic Dyskeratosis
33%
Scalp
33%
Overall Survival
33%
Statins
33%
Sentinel Node Metastasis
33%
Retrospective Cohort Study
33%
Bleeding Events
33%
Alcohol Flushing
33%
Hemorrhagic Complications
33%
Flap Repair
33%
Quality of Life Questionnaire
33%
Melanoma
33%
Interpolated Flap
33%
Nonuremic Calciphylaxis
33%
Advanced Tumor
33%
Basal Cell Carcinoma
33%
Key Binding
33%
Single Center
33%
Squamous Cell Carcinoma (SqCC)
33%
Signature Behaviors
33%
Visual Preference
33%
Brimonidine Gel
20%
Meatotomy
16%
Melanoma Patients
16%
Single Primary Melanoma
14%
Keratinocyte Carcinoma
13%
Quality of Life
13%
Improved Outcomes
11%
Tumor
11%
Verruca
7%
Myrmecia
7%
Carcinoma Cells
6%
Glow
6%
Asian Flush
6%
Cell Type Identification
6%
Classical Test Theory
6%
Depression Scale
6%
Hospital Anxiety
6%
Anxiety Scale
6%
Clinical Decision-making Tools
6%
Model Expression
6%
Skin Cancer Index
6%
Logistic Ridge Regression
6%
Regression Predictive Model
6%
Vibration Device
6%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
66%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
60%
Immunotherapy
36%
Squamous Cell Carcinoma
33%
Drug Repositioning
33%
Adverse Event
33%
Statin (Protein)
33%
Basal Cell Carcinoma
33%
Verruca Vulgaris
33%
Programmed Cell Death
33%
Randomized Clinical Trial
33%
Brimonidine
33%
Ethanol
33%
Overall Survival
33%
Syndrome
20%
Malignant Neoplasm
20%
Carcinoma
13%
Metastatic Melanoma
12%
Erythema
12%
Face Erythema
8%
Placebo
8%
Skin Cancer
6%
Observational Study
6%
Side Effect
6%
Beta Adrenergic Receptor Blocking Agent
6%
Monoclonal Antibody
6%
Reactive Oxygen Metabolite
6%
